Literature DB >> 20444963

Population analysis and epidemiological features of inhibitor-resistant-TEM-beta-lactamase-producing Escherichia coli isolates from both community and hospital settings in Madrid, Spain.

Oihane Martín1, Aránzazu Valverde, María I Morosini, Mario Rodríguez-Domínguez, Mercedes Rodríguez-Baños, Teresa M Coque, Rafael Cantón, Rosa del Campo.   

Abstract

Punctual mutations in the TEM-1 or TEM-2 gene may lead to inhibitor-resistant-TEM (IRT) beta-lactamases with resistance to beta-lactam-beta-lactamase inhibitor combinations and susceptibility to cephalosporins. The aim of this work was to analyze the current epidemiology of IRT beta-lactamases in contemporary clinical Escherichia coli. Isolates were prospectively collected in our hospital (2007 and 2008) from both outpatients (59.8%) and hospitalized patients (40.2%). The genetic relationships of the isolates were determined by XbaI pulsed-field gel electrophoresis, multilocus sequence typing, and phylogenetic group analysis. IRT genes were sequenced and located by hybridization, and the incompatibility group of the plasmids was determined. From a total of 3,556 E. coli isolates recovered during the study period, 152 (4.3%) showed reduced susceptibility to amoxicillin-clavulanate, with 18 of them producing IRT enzymes (0.5%). These were mostly recovered from urine (77.8%). A high degree of IRT diversity was detected (TEM-30, -32, -33, -34, -36, -37, -40, and -54), and the isolates were clonally unrelated but were mostly associated with phylogenetic group B2 (55.5%). In 12 out of 16 (75%) isolates, the bla(IRT) gene was plasmid located and transferred by conjugation in 9 of them, whereas chromosomal localization was demonstrated in 4 isolates (25%). The sizes of the plasmids ranged from 40 kb (IncN) to 100 kb (IncFII, IncFI/FIIA), and they showed different restriction patterns by restriction fragment length polymorphism analysis. Unlike extended-spectrum beta-lactamase producers, the frequency of IRT producers remains low in both community and hospital settings, with most of them causing urinary tract infections. Although bla(IRT) genes are mainly associated with plasmids, they can be also located in the chromosome. Despite this situation, clonal expansion and/or gene dispersion was not observed, denoting the independent emergence of these enzymes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20444963      PMCID: PMC2897472          DOI: 10.1128/JCM.00608-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing.

Authors:  R Cantón; M Pérez-Vázquez; A Oliver; B Sánchez Del Saz; M O Gutiérrez; M Martínez-Ferrer; F Baquero
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period.

Authors:  Elisenda Miró; Ferran Navarro; Beatriz Mirelis; Montserrat Sabaté; Alba Rivera; Pere Coll; Guillem Prats
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

3.  Emergence and dissemination of Enterobacteriaceae isolates producing CTX-M-1-like enzymes in Spain are associated with IncFII (CTX-M-15) and broad-host-range (CTX-M-1, -3, and -32) plasmids.

Authors:  Angela Novais; Rafael Cantón; Raquel Moreira; Luísa Peixe; Fernando Baquero; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

Review 4.  IRT and CMT beta-lactamases and inhibitor resistance.

Authors:  R Cantón; M I Morosini; O Martín; O Martín S de la Maza; E Gomez G de la Pedrosa
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

5.  The 120 592 bp IncF plasmid pRSB107 isolated from a sewage-treatment plant encodes nine different antibiotic-resistance determinants, two iron-acquisition systems and other putative virulence-associated functions.

Authors:  R Szczepanowski; S Braun; V Riedel; S Schneiker; I Krahn; A Pühler; A Schlüter
Journal:  Microbiology       Date:  2005-04       Impact factor: 2.777

6.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

7.  Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.

Authors:  Zeki Yumuk; Gokhan Afacan; Marie-Hélène Nicolas-Chanoine; Albert Sotto; Jean-Philippe Lavigne
Journal:  J Antimicrob Chemother       Date:  2008-05-02       Impact factor: 5.790

8.  Optimization of computer software settings improves accuracy of pulsed-field gel electrophoresis macrorestriction fragment pattern analysis.

Authors:  William M Duck; Christine D Steward; Shailen N Banerjee; John E McGowan; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing.

Authors:  Siu Ha Lau; Suganya Reddy; John Cheesbrough; Frederick J Bolton; Geraldine Willshaw; Tom Cheasty; Andrew J Fox; Mathew Upton
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

10.  armA and aminoglycoside resistance in Escherichia coli.

Authors:  Bruno González-Zorn; Tirushet Teshager; María Casas; María C Porrero; Miguel A Moreno; Patrice Courvalin; Lucas Domínguez
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

View more
  6 in total

1.  In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase.

Authors:  David M Livermore; Marina Warner; Dorota Jamrozy; Shazad Mushtaq; Wright W Nichols; Nazim Mustafa; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

2.  Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: a multicenter external proficiency study using a well-defined collection of Escherichia coli strains.

Authors:  Aida Ripoll; Juan-Carlos Galán; Cristina Rodríguez; Nuria Tormo; Concepción Gimeno; Fernando Baquero; Luis Martínez-Martínez; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

3.  Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.

Authors:  Rebecca I Waltner-Toews; David L Paterson; Zubair A Qureshi; Hanna E Sidjabat; Jennifer M Adams-Haduch; Kathleen A Shutt; Mark Jones; Guo-Bao Tian; Anthony W Pasculle; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

4.  Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli.

Authors:  Adriana Ortega; Jesús Oteo; Maitane Aranzamendi-Zaldumbide; Rosa M Bartolomé; Germán Bou; Emilia Cercenado; M Carmen Conejo; Juan José González-López; Mercedes Marín; Luis Martínez-Martínez; María Merino; Ferran Navarro; Antonio Oliver; Alvaro Pascual; Alba Rivera; Jesús Rodríguez-Baño; Irene Weber; Belén Aracil; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2012-04-09       Impact factor: 5.191

5.  Semirapid Detection of Piperacillin/Tazobactam Resistance and Extended-Spectrum Resistance to β-Lactams/β-Lactamase Inhibitors in Clinical Isolates of Escherichia coli.

Authors:  Ángel Rodríguez-Villodres; Alicia Gutiérrez Linares; Lydia Gálvez-Benitez; Jerónimo Pachón; José Antonio Lepe; Younes Smani
Journal:  Microbiol Spectr       Date:  2021-10-20

6.  Phenotypic and Genomic Characterization of AmpC-Producing Klebsiella pneumoniae From Korea.

Authors:  Mattia Palmieri; Stephane Schicklin; Andreu Coello Pelegrin; Sonia Chatellier; Christine Franceschi; Caroline Mirande; Yeon Joon Park; Alex van Belkum
Journal:  Ann Lab Med       Date:  2018-07       Impact factor: 3.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.